55 North Private Wealth’s Labcorp LH Stock Holding History

55 North Private Wealth’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-819	Closed	-$205K	–	221
2025 Q4	$205K	Buy	+819	New	+$218K	0.05%	189

Other funds holding LH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

55 North Private Wealth's LH Position: Q1 2026 in Review

55 North Private Wealth sold out of Labcorp (LH) in Q1 2026, closing a stake of 819 shares — an estimated $205K sold.

55 North Private Wealth first reported a position in LH in Q4 2025 and held it in 1 quarter. The position peaked at $205K in Q4 2025. 1,035 funds tracked by Wall St. Rank hold LH as of Q1 2026.

55 North Private Wealth reported no remaining Labcorp position as of Q1 2026 after selling out during the quarter.
55 North Private Wealth sold 819 Labcorp shares in Q1 2026, an estimated $205K.
55 North Private Wealth first reported a position in Labcorp in Q4 2025 and held it in 1 quarter.
55 North Private Wealth's Labcorp position peaked at $205K in Q4 2025.
1,035 funds tracked by Wall St. Rank held Labcorp as of Q1 2026.

Based on 55 North Private Wealth's 13F filing for Q1 2026, filed 17 Apr 2026.